This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diamond, J. R. Articles by Diamond, I. P. Search for Related Content PubMed PubMed Citation Articles by Diamond, J. R. Articles by Diamond, I. P.

American Journal of Pathology, Vol 141, 887-894, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome

JR Diamond, G Ding, J Frye and IP Diamond
Department of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033.

Mesangial cell proliferation, which is a harbinger of glomerulosclerosis, occurs in both immune and nonimmune glomerulopathies. The proximity of infiltrating glomerular macrophages to the contractile mesangial cells during acute puromycin aminonucleoside (PA) nephrosis suggests the possibility of a paracrine effect on mesangial cell growth. To test this, three maneuvers to either raise or lower the glomerular macrophage number during acute PA nephrosis (2 weeks after PA) were employed: 1) an essential fatty acid- deficient (EFAD) diet; 2) a cholesterol-supplemented diet (CSD); and 3) a single dose (600 rad) whole-body X-irradiation (XI) given to CSD-fed PA rats. Both the glomerular macrophage number and proliferation within the mesangium were evaluated immunohistochemically with ED-1, a mouse monoclonal anti-rat macrophage label, and 19A2, a mouse monoclonal anti- proliferating cell nuclear antigen (PCNA)/cyclin antibody, respectively. Immunohistochemical detection of 5'-bromo-2'-deoxyuridine (BrdU) incorporation confirmed that proliferation was occurring within the mesangial zones. The EFAD diet significantly reduced both the glomerular macrophage and PCNA/cyclin-positive cell number at 2 weeks after PA with a positive correlation (r = 0.89, P < 0.05). The CSD maneuver significantly increased both the glomerular macrophage and PCNA/cyclin cell number with a strong degree of correlation (r = 0.95, P < 0.01). X-irradiation administered to CSD-fed PA rats significantly lowered both the glomerular macrophage and PCNA/cyclin-positive cell number at 2 weeks. In all groups, the glomerular tufts did not express muscle actin using HHF 35, a specific immunolabel, suggesting that the proliferation in this model is not related to direct mesangial cell injury. This study shows that maneuvers that modulate the glomerular macrophage number are also associated with corresponding changes in the number of proliferating cells within the mesangium, suggesting a paracrine growth stimulation by the infiltrating macrophage during acute PA nephrosis. The infiltrating glomerular macrophage may be an effector mechanism for the propagation of initial glomerular injury to glomerulosclerosis by augmenting mesangial cell proliferation early in the course of this nonimmune progressive glomerulopathy.

This article has been cited by other articles:

				J. S. Duffield, P. G. Tipping, T. Kipari, J.-F. Cailhier, S. Clay, R. Lang, J. V. Bonventre, and J. Hughes Conditional Ablation of Macrophages Halts Progression of Crescentic Glomerulonephritis Am. J. Pathol., November 1, 2005; 167(5): 1207 - 1219. [Abstract] [Full Text] [PDF]

				N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance Am J Physiol Cell Physiol, August 1, 2004; 287(2): C548 - C557. [Abstract] [Full Text] [PDF]

				I. Z. A. Pawluczyk and K. P. G. Harris Cholesterol feeding activates macrophages to upregulate rat mesangial cell fibronectin production Nephrol. Dial. Transplant., February 1, 2000; 15(2): 161 - 166. [Abstract] [Full Text] [PDF]

				N. Bouriquet, M. Dupont, A. Herizi, A. Mimran, and D. Casellas Preglomerular Sudanophilia in L-NAME Hypertensive Rats : Involvement of Endothelin Hypertension, March 1, 1996; 27(3): 382 - 391. [Abstract] [Full Text]